search
Back to results

Double vs Single Intrauterine Insemination in Male Factor Infertility

Primary Purpose

Male Factor Infertility

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
intrauterine insemination
Sponsored by
Umraniye Education and Research Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Male Factor Infertility

Eligibility Criteria

18 Years - 40 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria: Couples trying to conceive for at least 6 months despite of regular sexual intercourse Female partner between 18-40 years old Male partner sperm analysis total motile sperm count between 1-10 million in at least 2 sperm analysis on different days. Exclusion Criteria: No patent fallopian tubes shown in hystero-salpingography Female partner with a uterine anomaly History of a previous ovarian surgery Known or suspected endometriosis in female partner Body-mass index (BMI) > 40 kg/m2

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Placebo Comparator

    Experimental

    Arm Label

    Single intrauterine insemination group

    Double intrauterine insemination group

    Arm Description

    When the leading follicle is greater than 17 mm following ovulation induction with follicle stimulating hormone (FSH) daily injections, ovulation trigger injection will be given to the participant. 36 hours after ovulation trigger injection single intrauterine insemination with partner's sperm collected on the same day will be done.

    When the leading follicle is greater than 17 mm following ovulation induction with follicle stimulating hormone (FSH) daily injections, ovulation trigger injection will be given to the participant. 24 and 48 hours after ovulation trigger injection intrauterine insemination will be done twice with partner's sperm collected on the specified days.

    Outcomes

    Primary Outcome Measures

    Rate of clinical pregnancy
    Pregnancy with fetal cardiac activity diagnosed by transvaginal ultrasonography

    Secondary Outcome Measures

    Rate of biochemical, ectopic pregnancies and rate of miscarriages
    Pregnancy outcomes including biochemical, ectopic pregnancies and miscarriages diagnosed by transvaginal ultrasonography

    Full Information

    First Posted
    May 1, 2023
    Last Updated
    May 30, 2023
    Sponsor
    Umraniye Education and Research Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05885516
    Brief Title
    Double vs Single Intrauterine Insemination in Male Factor Infertility
    Official Title
    Double vs Single Intrauterine Insemination in Male Factor Infertility - a Multicenter Randomized Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    May 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    June 5, 2023 (Anticipated)
    Primary Completion Date
    May 22, 2024 (Anticipated)
    Study Completion Date
    June 15, 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Umraniye Education and Research Hospital

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The aim of the study is to compare the pregnancy outcomes of single vs double intrauterine insemination (IUI) in couples with male factor infertility.
    Detailed Description
    The principle behind double intrauterine insemination in male factor infertility couples is to create a longer time frame for fertilization and to increase motile sperm number in female genital tract in order to increase pregnancy rates. There's a clinical equipoise on the benefits of performing double IUI in couples following ovarian hyperstimulation with daily follicle stimulating hormone injections in male factor subfertility. As it is stated in Cochrane database, there's a need for adequately powered, randomized, high-quality studies on this subject. In this study, as a result of a-priori power analysis 132 participants in each study arm is planned to be recruited in the study. Male factor infertility included in the study is defined as total motile sperm count (TPMSC) less than 10 million. TPMSC less than 1 million, female age greater than 40, uterine anomaly, no patent tubes shown in hysterosalpingography, history of ovarian surgery and known endometriosis will be excluded. Couples with two basal semen analysis with TPMSC between 1-10 million will be randomized to single or double IUI procedure. To accomplish this in approximately 1 year period, the study is planned as a multi-center study. The objective of the study is to compare the pregnancy outcomes of single and double intrauterine insemination groups, following ovarian hyperstimulation in couples with male factor subfertility.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Male Factor Infertility

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Care ProviderOutcomes Assessor
    Allocation
    Randomized
    Enrollment
    264 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Single intrauterine insemination group
    Arm Type
    Placebo Comparator
    Arm Description
    When the leading follicle is greater than 17 mm following ovulation induction with follicle stimulating hormone (FSH) daily injections, ovulation trigger injection will be given to the participant. 36 hours after ovulation trigger injection single intrauterine insemination with partner's sperm collected on the same day will be done.
    Arm Title
    Double intrauterine insemination group
    Arm Type
    Experimental
    Arm Description
    When the leading follicle is greater than 17 mm following ovulation induction with follicle stimulating hormone (FSH) daily injections, ovulation trigger injection will be given to the participant. 24 and 48 hours after ovulation trigger injection intrauterine insemination will be done twice with partner's sperm collected on the specified days.
    Intervention Type
    Procedure
    Intervention Name(s)
    intrauterine insemination
    Intervention Description
    Giving washed sperm concentrate into uterine cavity via a soft catheter
    Primary Outcome Measure Information:
    Title
    Rate of clinical pregnancy
    Description
    Pregnancy with fetal cardiac activity diagnosed by transvaginal ultrasonography
    Time Frame
    Within 4-6 weeks after insemination
    Secondary Outcome Measure Information:
    Title
    Rate of biochemical, ectopic pregnancies and rate of miscarriages
    Description
    Pregnancy outcomes including biochemical, ectopic pregnancies and miscarriages diagnosed by transvaginal ultrasonography
    Time Frame
    Within 3 months after insemination

    10. Eligibility

    Sex
    Female
    Gender Based
    Yes
    Gender Eligibility Description
    Eligibility is not based on self-representation of gender identity. Participants should have a uterus with at least one patent fallopian tube and an internal os to achieve intrauterine insemination.
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    40 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Couples trying to conceive for at least 6 months despite of regular sexual intercourse Female partner between 18-40 years old Male partner sperm analysis total motile sperm count between 1-10 million in at least 2 sperm analysis on different days. Exclusion Criteria: No patent fallopian tubes shown in hystero-salpingography Female partner with a uterine anomaly History of a previous ovarian surgery Known or suspected endometriosis in female partner Body-mass index (BMI) > 40 kg/m2
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Merve Dizdar, Speacialist
    Phone
    +905355962232
    Email
    mervedizdar@gmail.com
    First Name & Middle Initial & Last Name or Official Title & Degree
    Gürkan Bozdağ, Professor
    Phone
    +905327136326
    Email
    gbozdag75@yahoo.com

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    34260059
    Citation
    Rakic L, Kostova E, Cohlen BJ, Cantineau AE. Double versus single intrauterine insemination (IUI) in stimulated cycles for subfertile couples. Cochrane Database Syst Rev. 2021 Jul 14;7(7):CD003854. doi: 10.1002/14651858.CD003854.pub2.
    Results Reference
    background
    PubMed Identifier
    20457669
    Citation
    Bagis T, Haydardedeoglu B, Kilicdag EB, Cok T, Simsek E, Parlakgumus AH. Single versus double intrauterine insemination in multi-follicular ovarian hyperstimulation cycles: a randomized trial. Hum Reprod. 2010 Jul;25(7):1684-90. doi: 10.1093/humrep/deq112. Epub 2010 May 10.
    Results Reference
    background

    Learn more about this trial

    Double vs Single Intrauterine Insemination in Male Factor Infertility

    We'll reach out to this number within 24 hrs